Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuropsychological Tests | 36 | 2020 | 237 | 3.160 |
Why?
|
| Mental Disorders | 10 | 2024 | 105 | 2.760 |
Why?
|
| Cognition Disorders | 17 | 2017 | 181 | 1.470 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2018 | 27 | 1.400 |
Why?
|
| Geriatric Assessment | 16 | 2014 | 87 | 1.360 |
Why?
|
| Child Abuse | 2 | 2024 | 89 | 1.060 |
Why?
|
| Psychotic Disorders | 4 | 2022 | 20 | 1.000 |
Why?
|
| Adolescent | 27 | 2024 | 2995 | 1.000 |
Why?
|
| Exercise | 3 | 2018 | 469 | 0.970 |
Why?
|
| Young Adult | 19 | 2024 | 2631 | 0.960 |
Why?
|
| Health Risk Behaviors | 1 | 2024 | 7 | 0.930 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2024 | 18 | 0.930 |
Why?
|
| Gender Identity | 1 | 2024 | 21 | 0.930 |
Why?
|
| Male | 57 | 2024 | 13034 | 0.920 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2022 | 95 | 0.920 |
Why?
|
| Female | 61 | 2024 | 14650 | 0.900 |
Why?
|
| Age Factors | 14 | 2016 | 724 | 0.870 |
Why?
|
| Parkinson Disease | 4 | 2016 | 38 | 0.860 |
Why?
|
| Neuropsychology | 2 | 2020 | 10 | 0.820 |
Why?
|
| Educational Status | 8 | 2016 | 111 | 0.750 |
Why?
|
| Humans | 68 | 2024 | 27136 | 0.740 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 112 | 0.740 |
Why?
|
| Psychometrics | 8 | 2016 | 118 | 0.740 |
Why?
|
| Sodium Benzoate | 1 | 2020 | 2 | 0.720 |
Why?
|
| Australia | 8 | 2024 | 26 | 0.710 |
Why?
|
| Subthalamic Nucleus | 2 | 2012 | 3 | 0.710 |
Why?
|
| Longitudinal Studies | 16 | 2021 | 404 | 0.710 |
Why?
|
| Deep Brain Stimulation | 2 | 2012 | 7 | 0.700 |
Why?
|
| Antifungal Agents | 1 | 2020 | 59 | 0.690 |
Why?
|
| Delusions | 3 | 2015 | 3 | 0.680 |
Why?
|
| Conduct Disorder | 2 | 2017 | 2 | 0.680 |
Why?
|
| Adult | 27 | 2024 | 7499 | 0.670 |
Why?
|
| Health Status | 4 | 2015 | 145 | 0.660 |
Why?
|
| Aged | 41 | 2019 | 5228 | 0.650 |
Why?
|
| Disease Progression | 2 | 2018 | 458 | 0.650 |
Why?
|
| Vocabulary | 2 | 2016 | 7 | 0.570 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2017 | 10 | 0.560 |
Why?
|
| Child Language | 1 | 2016 | 2 | 0.550 |
Why?
|
| Language Development Disorders | 1 | 2016 | 3 | 0.550 |
Why?
|
| Aged, 80 and over | 28 | 2019 | 1943 | 0.550 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 67 | 0.540 |
Why?
|
| Employment | 1 | 2016 | 46 | 0.530 |
Why?
|
| Child | 12 | 2024 | 2163 | 0.520 |
Why?
|
| Middle Aged | 27 | 2024 | 6906 | 0.520 |
Why?
|
| Mental Health | 1 | 2016 | 97 | 0.510 |
Why?
|
| Psychomotor Performance | 4 | 2011 | 72 | 0.510 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2015 | 2 | 0.500 |
Why?
|
| Hallucinations | 1 | 2015 | 4 | 0.490 |
Why?
|
| Task Performance and Analysis | 2 | 2015 | 41 | 0.490 |
Why?
|
| Substance-Related Disorders | 6 | 2022 | 177 | 0.480 |
Why?
|
| Queensland | 4 | 2018 | 5 | 0.480 |
Why?
|
| Marijuana Smoking | 1 | 2015 | 31 | 0.480 |
Why?
|
| Mortality | 1 | 2015 | 43 | 0.470 |
Why?
|
| Tobacco Use | 1 | 2015 | 85 | 0.450 |
Why?
|
| Follow-Up Studies | 8 | 2017 | 988 | 0.450 |
Why?
|
| Reproducibility of Results | 23 | 2015 | 751 | 0.400 |
Why?
|
| Residence Characteristics | 10 | 2013 | 101 | 0.390 |
Why?
|
| Intelligence | 6 | 2008 | 27 | 0.370 |
Why?
|
| Cohort Studies | 7 | 2022 | 864 | 0.370 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2020 | 7 | 0.340 |
Why?
|
| Case-Control Studies | 5 | 2020 | 707 | 0.330 |
Why?
|
| Pre-Eclampsia | 2 | 2020 | 48 | 0.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 100 | 0.290 |
Why?
|
| Child, Preschool | 5 | 2020 | 1103 | 0.290 |
Why?
|
| Self Report | 4 | 2015 | 116 | 0.280 |
Why?
|
| Child Behavior Disorders | 3 | 2020 | 25 | 0.270 |
Why?
|
| Registries | 3 | 2019 | 384 | 0.260 |
Why?
|
| Treatment Outcome | 3 | 2020 | 2285 | 0.260 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2020 | 17 | 0.250 |
Why?
|
| Risk Factors | 5 | 2021 | 2035 | 0.250 |
Why?
|
| Memory Disorders | 3 | 2015 | 47 | 0.250 |
Why?
|
| Cognition | 6 | 2011 | 298 | 0.240 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 931 | 0.240 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 126 | 0.230 |
Why?
|
| Foster Home Care | 1 | 2024 | 6 | 0.230 |
Why?
|
| Intelligence Tests | 4 | 2015 | 25 | 0.230 |
Why?
|
| Denmark | 3 | 2020 | 26 | 0.220 |
Why?
|
| Prospective Studies | 4 | 2020 | 1219 | 0.220 |
Why?
|
| Mortality, Premature | 2 | 2020 | 3 | 0.220 |
Why?
|
| Global Health | 2 | 2012 | 43 | 0.200 |
Why?
|
| Semantics | 1 | 2002 | 11 | 0.200 |
Why?
|
| Brain Diseases | 4 | 2006 | 35 | 0.200 |
Why?
|
| Reference Values | 7 | 2011 | 199 | 0.200 |
Why?
|
| Alzheimer Disease | 3 | 2013 | 211 | 0.200 |
Why?
|
| Comorbidity | 3 | 2020 | 252 | 0.190 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 13 | 0.190 |
Why?
|
| Cannabis | 1 | 2022 | 42 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 39 | 0.180 |
Why?
|
| Visual Perception | 4 | 2013 | 44 | 0.180 |
Why?
|
| Placebos | 1 | 2020 | 46 | 0.180 |
Why?
|
| Mood Disorders | 2 | 2019 | 25 | 0.180 |
Why?
|
| Anxiety Disorders | 2 | 2019 | 59 | 0.180 |
Why?
|
| Wounds and Injuries | 2 | 2012 | 166 | 0.180 |
Why?
|
| Global Burden of Disease | 1 | 2020 | 4 | 0.180 |
Why?
|
| Life Expectancy | 1 | 2020 | 20 | 0.170 |
Why?
|
| Sensitivity and Specificity | 8 | 2017 | 509 | 0.170 |
Why?
|
| Schizophrenia | 1 | 2020 | 46 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 108 | 0.170 |
Why?
|
| Depression | 4 | 2021 | 212 | 0.170 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 205 | 0.170 |
Why?
|
| Alcoholism | 2 | 2020 | 117 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 49 | 0.170 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2015 | 216 | 0.160 |
Why?
|
| Time Factors | 5 | 2016 | 1571 | 0.160 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2019 | 10 | 0.160 |
Why?
|
| Wechsler Scales | 3 | 2003 | 11 | 0.160 |
Why?
|
| Cognitive Dysfunction | 2 | 2013 | 259 | 0.160 |
Why?
|
| Aging | 5 | 2007 | 952 | 0.160 |
Why?
|
| Medicare | 1 | 2019 | 119 | 0.150 |
Why?
|
| Malingering | 2 | 2011 | 8 | 0.150 |
Why?
|
| Infant | 3 | 2017 | 967 | 0.150 |
Why?
|
| Logistic Models | 2 | 2017 | 399 | 0.140 |
Why?
|
| Transferrin | 1 | 2017 | 9 | 0.140 |
Why?
|
| Ferritins | 1 | 2017 | 24 | 0.140 |
Why?
|
| Preliminary Data | 1 | 2016 | 4 | 0.140 |
Why?
|
| Memory, Short-Term | 3 | 2014 | 62 | 0.140 |
Why?
|
| Predictive Value of Tests | 10 | 2008 | 472 | 0.140 |
Why?
|
| Quality of Life | 1 | 2020 | 467 | 0.140 |
Why?
|
| Risk | 1 | 2017 | 133 | 0.130 |
Why?
|
| Algorithms | 5 | 2006 | 422 | 0.130 |
Why?
|
| Demography | 9 | 2006 | 91 | 0.130 |
Why?
|
| Attention | 6 | 2013 | 90 | 0.130 |
Why?
|
| Iron | 1 | 2017 | 108 | 0.130 |
Why?
|
| Parents | 1 | 2017 | 122 | 0.130 |
Why?
|
| Verbal Learning | 2 | 2006 | 11 | 0.130 |
Why?
|
| Pregnancy | 4 | 2021 | 1150 | 0.130 |
Why?
|
| United Kingdom | 3 | 2020 | 70 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2016 | 251 | 0.120 |
Why?
|
| Universities | 1 | 2015 | 116 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2008 | 298 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 656 | 0.110 |
Why?
|
| Independent Living | 1 | 2014 | 14 | 0.110 |
Why?
|
| Checklist | 1 | 2013 | 21 | 0.110 |
Why?
|
| Epilepsy | 1 | 2013 | 34 | 0.110 |
Why?
|
| United States | 1 | 2019 | 2061 | 0.100 |
Why?
|
| Students | 1 | 2015 | 191 | 0.100 |
Why?
|
| Antiparkinson Agents | 1 | 2012 | 3 | 0.100 |
Why?
|
| Prevalence | 3 | 2024 | 478 | 0.100 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 930 | 0.100 |
Why?
|
| Verbal Behavior | 2 | 2008 | 9 | 0.090 |
Why?
|
| Memory | 3 | 2013 | 71 | 0.090 |
Why?
|
| Regression Analysis | 6 | 2008 | 209 | 0.090 |
Why?
|
| Suicide | 2 | 2020 | 11 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2010 | 163 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2017 | 388 | 0.080 |
Why?
|
| Health Surveys | 3 | 2016 | 77 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 2 | 2006 | 43 | 0.080 |
Why?
|
| Language | 5 | 2013 | 62 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 353 | 0.080 |
Why?
|
| Mothers | 2 | 2021 | 112 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 446 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2011 | 211 | 0.080 |
Why?
|
| Mental Processes | 2 | 2005 | 16 | 0.080 |
Why?
|
| Medulloblastoma | 1 | 2007 | 18 | 0.070 |
Why?
|
| Dementia | 2 | 2010 | 90 | 0.070 |
Why?
|
| Mental Recall | 1 | 2007 | 45 | 0.070 |
Why?
|
| Sex Factors | 3 | 2012 | 452 | 0.070 |
Why?
|
| Problem Solving | 1 | 2005 | 28 | 0.060 |
Why?
|
| Speech Perception | 1 | 2005 | 28 | 0.060 |
Why?
|
| Disease | 1 | 2004 | 15 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 37 | 0.060 |
Why?
|
| Psychological Theory | 1 | 2004 | 29 | 0.060 |
Why?
|
| Neoplasms | 1 | 2013 | 768 | 0.060 |
Why?
|
| Age Distribution | 3 | 2011 | 70 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2003 | 9 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 119 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 68 | 0.050 |
Why?
|
| Community Health Planning | 2 | 2013 | 14 | 0.050 |
Why?
|
| Finland | 1 | 2022 | 4 | 0.050 |
Why?
|
| ADAMTS13 Protein | 2 | 2015 | 126 | 0.050 |
Why?
|
| ADAM Proteins | 2 | 2015 | 102 | 0.050 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2011 | 27 | 0.050 |
Why?
|
| African Americans | 1 | 2003 | 350 | 0.050 |
Why?
|
| Anxiety | 1 | 2021 | 140 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 66 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2012 | 846 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 144 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 2 | 2008 | 46 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 108 | 0.040 |
Why?
|
| Oklahoma | 2 | 2014 | 978 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 290 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 139 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 227 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2016 | 2456 | 0.030 |
Why?
|
| Convalescence | 1 | 2015 | 6 | 0.030 |
Why?
|
| Plasma Exchange | 1 | 2015 | 103 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 299 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 408 | 0.030 |
Why?
|
| Family | 1 | 2013 | 98 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 368 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2011 | 76 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 553 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 21 | 0.020 |
Why?
|
| Survivors | 1 | 2007 | 36 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 101 | 0.020 |
Why?
|
| Reference Standards | 1 | 2006 | 54 | 0.020 |
Why?
|
| Bias | 1 | 2006 | 40 | 0.020 |
Why?
|
| Repression, Psychology | 1 | 2005 | 5 | 0.020 |
Why?
|
| Paired-Associate Learning | 1 | 2005 | 6 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2005 | 8 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2005 | 77 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2003 | 20 | 0.010 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 9 | 0.010 |
Why?
|
| Reading | 1 | 2003 | 17 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 78 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2007 | 605 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 148 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 711 | 0.010 |
Why?
|
| Motivation | 1 | 2003 | 210 | 0.010 |
Why?
|